NCT04664153 Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT04651829 Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution Status COMPLETED Phase N/A
NCT04643457 A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis Status COMPLETED Phase PHASE1/PHASE2
NCT04633616 Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients Status COMPLETED Phase NA
NCT04626297 A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) Status COMPLETED Phase PHASE3
NCT04615962 Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects. Status UNKNOWN Phase PHASE1
NCT04613037 Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis Status COMPLETED Phase EARLY_PHASE1
NCT04605094 Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT04598269 Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT04587453 Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT04564755 Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis Status NO_LONGER_AVAILABLE Phase N/A
NCT04562116 A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT04556461 Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function Status COMPLETED Phase PHASE2
NCT04553224 Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis Status COMPLETED Phase NA
NCT04544943 Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT04539639 Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT04530643 A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon) Status COMPLETED Phase PHASE2